Background/Aims: A diagnosis of hepatorenal syndrome (HRS) is based on a differential evaluation of acute kidney injury (AKI), which may aggravate the clinical course. This study assessed the clinical significance of the urinary neutrophil gelatinase-associated lipocalin (u-NGAL) levels in a differential diagnosis of AKI in patients with liver cirrhosis (LC). Methods: Patients with LC who developed AKI were enrolled prospectively. Clinically, patients with AKI were classified into prerenal azotemia (PRA), HRS, and acute tubular necrosis (ATN) groups. Results: Fifty-five patients (male, 74.5%) with LC who exhibited AKI upon admission were enrolled; 28, 9, and 18 patients were included in the PRA, HRS, and ATN groups, respectively. The baseline model for end-stage liver disease (MELD) scores was similar in the subgroups. The median event creatinine level, measured at the time of the AKI diagnosis, was similar in the HRS and ATN subgroups. On the other hand, the median event u-NGAL level differed significantly between the three subgroups (PRA, HRS, and ATN: 37 vs. 134 vs. 2,625 ng/mL, p=0.003). In particular, the median u-NGAL level of the HRS group was clearly different from those of the PRA (p<0.001) and ATN (p<0.001) groups. Multivariable analysis revealed the natural logarithm of the u-NGAL level (hazard ratio [HR] 1.77, p=0.031) and the MELD score (HR 1.17, p=0.027) to be independent prognostic factors for in-hospital mortality in patients with LC and AKI. Conclusions: The median u-NGAL level differentiated HRS from ATN and served as a clinical indicator of in-hospital mortality for patients with LC and AKI. (Korean J Gastroenterol 2019;74:212-218) 
INTRODUCTION
The prevalence of acute kidney injury (AKI) is approximately 20-50% in patients with advanced liver cirrhosis (LC). [1] [2] [3] AKI is associated with a four-fold increased risk of mortality.
prognosis of patients with LC and AKI is poor; AKI in patients with LC has attracted increasing attention. The recently revised definition of AKI in patients with LC highlights the need to address elevations in the serum creatinine (sCr) level immediately, even small elevations. The differential diagnosis of HRS still requires 48 hours of observation during albumin infusion. 5 AKI management varies according to etiology. Therefore, biomarkers differentiating HRS from other diseases are needed.
Recently, the levels of urinary neutrophil gelatinase-associated lipocalin (u-NGAL), L-type fatty acid binding protein (L-FABP),
interleukin-18 (IL-18), and kidney injury molecule-1 (KIM-1)
have been suggested to assist in the differential diagnosis of AKI in patients with LC. [6] [7] [8] [9] [10] Several studies have suggested that u-NGAL facilitates the early detection and differential diagnosis of AKI in patients with LC. The u-NGAL level in HRS is between that of ATN and PRA. 6, 7, 11, 12 ATN has the highest level of u-NGAL protein because the u-NGAL protein is synthesized by an injured kidney epithelium. 6 On the other hand, Korean data supporting the clinical utility of the u-NGAL level are scarce. Therefore, this study examined the utility of the u-NGAL level for AKI management in patients with LC.
SUBJECTS AND METHODS

Patients
Between October 2015 and June 2016, this study enrolled patients hospitalized with LC and grade 1 AKI (based on the recent International Club of Ascites-AKI criteria). 13 Clinically, AKI patients were divided (by physician consensus) into three subgroups according to the etiology: PRA (group 1), HRS (group 2), and ATN (group 3). A diagnosis of PRA was made in patients with a history of volume depletion associated with the fractional excretion of sodium <1%, and a return of the sCr level to within 25% of the baseline by 48 hours after volume replacement. 18 A diagnosis of HRS was made using the International Ascites Club criteria: if improvement was not evident after 48 hours of diuretic withdrawal and volume expansion with albumin; in the absence of shock; and in the presence of nephrotoxic medication, parenchymal kidney disease (absence of proteinuria >500 mg/day), microhematuria, and abnormal kidney imaging findings. 5 A diagnosis of ATN was made in those exposed to nephrotoxic agents or exhibited volume depletion and fractional excretion of sodium >2%. 19 Urine samples used for u-NGAL testing were collected at the time of the AKI diagnosis and were centrifuged immediately after collection at 2,000 G for 10 minutes.
The supernatant was stored at -80℃ for batched analysis.
The u-NGAL level was measured by an immunoassay (employing the ARCHITECT platform, Beckman coulter AU5800; Bioporto, Copenhagen, Denmark).
Endpoints
Based on the measurements of the u-NGAL level, this study examined whether there were significant differences between 214 이종호 등. 소변 내 호중구 젤라틴 분해효소 연관 리포칼린의 유용성
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Statistical analysis
The categorical variables are expressed as numbers with percentages and continuous variables as medians with ranges.
These parameters were compared using a chi-square test or
Fisher's exact test and a Student's independent t-test.
Comparisons between the three groups were performed using an ANOVA, and comparisons between any two of the groups were performed using a Student's independent t-test. Univariate 
RESULTS
Baseline characteristics
Fifty five patients with LC and AKI were enrolled, of whom 28, 9, and 18 were classified into the PRA, HRS, and ATN groups, respectively (Table 1) . Seventy-five percent of the patients were male, and the proportions of males were similar in the three groups (61-80%). The median Child-Pugh and MELD scores were 10 (range, 5-14) and 21 (range, 7-47), respectively, and were comparable between the groups.
Eighteen patients developed either a urinary tract infection or other infections. Urinary tract infection was the most common infection, and its incidence was similar in the groups.
The median baseline sCr level differed significantly between the groups, particularly between the PRA and HRS groups and between the ATN and HRS groups. The median sCr levels in the PRA, HRS, and ATN groups were 1.44 (range, 0.60-3.40), u-NGAL levels in the PRA, HRS, and ATN groups were 3.6, 4.9, and 7.9 Ln ng/mL, respectively (Fig. 1) . The median Ln u-NGAL level was much higher in the ATN group than in the PRA and HRS groups ( Table 2) .
Of the 55 patients, 17 (30.9 %) died prior to discharge.
The in-hospital mortality rates in the PRA, HRS, and ATN groups were 7.1% (2 of 28), 55.5% (5 of 9), and 55.5% (10 of 18), respectively. The median survival times of the patients who died prior to discharge were 18, 5, and 12 days in the PRA, HRS, and ATN groups, respectively. The cause of death in the two patients in the PRA group was HCC progression.
The causes of death in the HRS group were HRS progression in four patients and esophageal varix bleeding in one patient.
In the ATN group, the causes of death were sepsis due to spontaneous bacterial peritonitis in two patients, liver ab-scesses in two, varix bleeding in two, cardiac arrest in one, and HCC progression in three patients. tween the PRA and HRS groups (p<0.001) (Fig. 2) .
Survival curves
Survival analysis regarding the u-NGAL level was based on a logarithmic scale because the u-NGAL level was not distributed normally. The number of measurements of the u-NGAL levels was small. Therefore, they were divided into quartiles to confirm the cut-off value. The Ln u-NGAL level in <25% quartile (Q) 1, 25-50% (Q2), 50-75% (Q3), and ≥75%
(Q4) was <3.6, 3.6-4.9, 4.9-7, and ≥7, respectively. The median survival time in Q1, Q2, Q3, and Q4 was 0.3 (range 0.1-0.5), 1.2 (range 0-3.2), 0.4 (range, 0-1.9) and 0.4 (range, 0-1.8) months, respectively. A significant difference was noted when Q1 was compared with the other groups (Fig. 3 ). ocalin-2 gene and is expressed in a number of tissues and cell types, particularly neutrophils. [21] [22] [23] u-NGAL expression is upregulated markedly in the kidney after injury and is secreted at the early stages of AKI. 7, [21] [22] [23] In patients with LC and AKI, the u-NGAL level is elevated prior to the increase in Cr level. 4 In a previous study, the u-NGAL level was significantly higher in ATN patients than in non-ATN patients and was useful for detecting AKI early in hospitalized cirrhotic patients. 4, 6, 7, 12 According to Verna et al., 6 27 Finally, approximately one-third of the study participants were diagnosed with HCC. Because the presence of HCC seriously affected the survival rate of the patients, it was a limitation in predicting in-hospital mortality.
Factors predictive of in-hospital mortality
In conclusion, the u-NGAL level distinguished the three AKI groups better than the sCr level. Furthermore, the u-NGAL level predicted the in-hospital mortality independent of the MELD score. Therefore, measurements of the u-NGAL level in patients with both LC and AKI can assist in making an early diagnosis of the cause of AKI and may be prognostic.
If the u-NGAL level is high in patients with LC and AKI, serial follow-up will be needed to determine if HRS will progress to ATN and if early renal replacement therapy is necessary in such patients, thereby improving their prognosis.
